BG
Bellevue Group Portfolio holdings
AUM
$4.54B
This Quarter Return
+9.44%
1 Year Return
+22.5%
3 Year Return
+98.22%
5 Year Return
+159.37%
10 Year Return
–
AUM
$553M
AUM Growth
+$553M
(+4.1%)
Cap. Flow
-$6.09M
Cap. Flow
% of AUM
-1.1%
Top 10 Holdings %
Top 10 Hldgs %
30.71%
Holding
131
New
7
Increased
28
Reduced
30
Closed
10
Top Buys
| 1 |
Viatris
VTRS
|
$4.42M |
| 2 |
Ligand Pharmaceuticals
LGND
|
$3.66M |
| 3 |
AKRX
Akorn, Inc.
AKRX
|
$3.41M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
$3.22M |
| 5 |
ENDP
Endo International plc
ENDP
|
$2.78M |
Top Sells
| 1 |
CVS Health
CVS
|
$6.24M |
| 2 |
Cardinal Health
CAH
|
$5.79M |
| 3 |
MDVN
MEDIVATION, INC.
MDVN
|
$4.7M |
| 4 |
STJ
St Jude Medical
STJ
|
$4.68M |
| 5 |
Humana
HUM
|
$3.4M |
Sector Composition
| 1 | Healthcare | 92.11% |
| 2 | Financials | 0.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Vertex Pharmaceuticals
VRTX
$102B
| $7.41M | 1.34% |
85,000
+19,000
| +29% | +$1.66M |
|
|
SHPG
27
DELISTED
Shire pic
SHPG
| $7.38M | 1.33% |
38,090
-760
| -2% | -$147K |
|
|
ABMD
28
DELISTED
Abiomed Inc
ABMD
| $7.13M | 1.29% |
55,450
-1,750
| -3% | -$225K |
|
|
AKRX
29
DELISTED
Akorn, Inc.
AKRX
| $6.87M | 1.24% |
252,000
+125,000
| +98% | +$3.41M |
|
|
ARIA
30
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $6.78M | 1.22% |
495,000
| – | – |
|
|
AGN
31
DELISTED
Allergan plc
AGN
| $6.77M | 1.22% |
29,400
-5,700
| -16% | -$1.31M |
|
|
CERN
32
DELISTED
Cerner Corp
CERN
| $6.08M | 1.1% |
98,500
+38,500
| +64% | +$2.38M |
|
|
ALXN
33
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $6.05M | 1.09% |
49,400
| – | – |
|
34
BioMarin Pharmaceuticals
BMRN
$11.3B
| $6.01M | 1.09% |
65,000
| – | – |
|
35
Johnson & Johnson
JNJ
$429B
| $5.91M | 1.07% |
50,000
| – | – |
|
|
MNK
36
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $5.64M | 1.02% |
80,800
+33,800
| +72% | +$2.36M |
|
|
BCR
37
DELISTED
CR Bard Inc.
BCR
| $5.61M | 1.01% |
25,000
| – | – |
|
38
Coherus Oncology, Inc. Common Stock
CHRS
$146M
| $5.41M | 0.98% |
202,000
-102,000
| -34% | -$2.73M |
|
|
AMSG
39
DELISTED
Amsurg Corp
AMSG
| $4.79M | 0.86% |
71,400
-2,600
| -4% | -$174K |
|
40
Cooper Companies
COO
$13.3B
| $4.21M | 0.76% |
23,500
| – | – |
|
41
Masimo
MASI
$7.43B
| $4.16M | 0.75% |
70,000
-5,000
| -7% | -$297K |
|
42
McKesson
MCK
$85.9B
| $4M | 0.72% |
24,000
-2,000
| -8% | -$334K |
|
|
NUVA
43
DELISTED
NuVasive, Inc.
NUVA
| $4M | 0.72% |
60,000
| – | – |
|
44
Ionis Pharmaceuticals
IONS
$9.64B
| $3.96M | 0.71% |
108,000
| – | – |
|
45
Perrigo
PRGO
$3.21B
| $3.94M | 0.71% |
42,700
-1,300
| -3% | -$120K |
|
46
iShares Biotechnology ETF
IBB
$5.68B
| $3.91M | 0.71% |
13,500
+5,000
| +59% | +$1.45M |
|
47
Halozyme
HALO
$8.75B
| $3.84M | 0.69% |
318,000
| – | – |
|
|
ENDP
48
DELISTED
Endo International plc
ENDP
| $3.83M | 0.69% |
190,000
+138,000
| +265% | +$2.78M |
|
|
CYTO
49
DELISTED
Altamira Therapeutics Ltd. Common Shares 0.01 SF (Bermuda)
CYTO
| $3.75M | 0.68% |
2,169,625
| – | – |
|
|
ESRX
50
DELISTED
Express Scripts Holding Company
ESRX
| $3.49M | 0.63% |
49,500
-15,500
| -24% | -$1.09M |
|